Lisa Rojkjaer, Chief Medical Officer at Viracta Therapeutics, Inc. (VIRX), sold 4,541 shares at $4.80 ($22K) on 2021-11-26, disclosed to the SEC on 2021-11-29.
Open-market sale of $22k VIRX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.80 | 1,950 | $9K | 42.8% |
| 2 | $4.82 | 2,591 | $12K | 57.2% |
| Total | $4.81 avg | 4,541 | $22K | 100% |
| Filing → |
| VIRX | SELL | 2022-08-29 | $9K | — | Filing → |
| VIRX | SELL | 2022-05-27 | $4K | — | Filing → |
| VIRX | SELL | 2022-03-01 | $7K | — | Filing → |